Advertisement

European Journal of Clinical Pharmacology

, Volume 54, Issue 9–10, pp 753–760 | Cite as

Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects

  • K. Hashimoto
  • T. Shirafuji
  • H. Sekino
  • O. Matsuoka
  • H. Sekino
  • O. Onnagawa
  • T. Okamoto
  • S. Kudo
  • J. Azuma
PHARMOCOKINETICS AND DISPOSITION

Abstract

Objectives: The study was conducted to investigate whether oral co-administration with citrus juices significantly affects the pharmacokinetics and/or pharmacodynamics of pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy male subjects. Grapefruit juice and orange juice, which were both commercially available, were used in this study.

Methods: Sixteen healthy male Japanese subjects participated in this study and were divided into two groups for grapefruit juice and orange juice treatment. The study followed an open-labelled crossover design, comparing the effects of a single oral dose of 2 mg pranidipine taken together with 250 ml citrus juice or 250 ml water. Serum pharmacokinetics of pranidipine, adverse reactions, blood pressure, heart rate, 12-lead ECG, haematology, clinical chemistry and urinalysis were measured throughout the study.

Results: For grapefruit juice, mean Cmax and AUC0–24 h were significantly higher than those of water (P = 0.0003 and 0.0005, respectively, ANOVA) with the ratios of log transformed values being 1.50 and 1.74, respectively. There were no differences in tmax and t½ between the juice and water treatments. A significant increase in heart rate (P = 0.0240, ANOVA with repeated measurements) was observed in the juice treatment whereas there were no significant differences in systolic and diastolic blood pressure between the two treatments. For orange juice, a small decrease in mean Cmax was observed compared with water (P = 0.0218, ANOVA) with the ratio being 0.86, but there was no significant difference in AUC0–24 h between the two treatments. No marked differences were observed in tmax and t½. Oral pranidipine administration with orange juice did not affect heart rate, systolic and diastolic blood pressures or other parameters for safety evaluation.

Conclusions: Oral co-administration with grapefruit juice and pranidipine was associated with increased bioavailability and changed the pharmacodynamics of pranidipine, particularly with regard to heart rate. Orange juice intake with pranidipine did not markedly affect the pharmacokinetics and no clinically significant changes were observed in the pharmacodynamics and safety evaluation.

Key words Pranidipine Grapefruit juice/orange juice interaction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • K. Hashimoto
    • 1
  • T. Shirafuji
    • 2
  • H. Sekino
    • 1
  • O. Matsuoka
    • 1
  • H. Sekino
    • 1
  • O. Onnagawa
    • 3
  • T. Okamoto
    • 2
  • S. Kudo
    • 4
  • J. Azuma
    • 5
  1. 1.Sekino Hospital, Tokyo, JapanJP
  2. 2.Otsuka Pharmaceuticals, Osaka, JapanJP
  3. 3.Toray Research Center, Analytical Science Laboratories, Kamakura, JapanJP
  4. 4.Tokushima Research Institute, Otsuka Pharmaceuticals, 463-10 Kagasuno Kawauchi-cho, Tokushima 771-0192, Japan Tel.: +81-886-65-2126, Fax: +81-886-65-6976JP
  5. 5.Osaka University, Osaka, JapanJP

Personalised recommendations